These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 15373113

  • 1. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
    MMW Fortschr Med; 2004 May 27; 146(22):48. PubMed ID: 15373113
    [No Abstract] [Full Text] [Related]

  • 2. Prevention of NSAID-gastropathy.
    Ardizzone S, Bianchi Porro G.
    Ital J Gastroenterol; 1996 Dec 27; 28 Suppl 4():33-6. PubMed ID: 9032581
    [Abstract] [Full Text] [Related]

  • 3. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Chan FK, Sung JJ.
    N Engl J Med; 1998 Jul 30; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
    [No Abstract] [Full Text] [Related]

  • 4. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK, Graham DY.
    Aliment Pharmacol Ther; 2004 May 15; 19(10):1051-61. PubMed ID: 15142194
    [Abstract] [Full Text] [Related]

  • 5. Misoprostol and NSAID ulcers.
    Isaacs P.
    Am J Gastroenterol; 1996 Feb 15; 91(2):187-8. PubMed ID: 8607480
    [No Abstract] [Full Text] [Related]

  • 6. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Feb 15; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [Abstract] [Full Text] [Related]

  • 7. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND.
    Ital J Gastroenterol Hepatol; 1999 Feb 15; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [Abstract] [Full Text] [Related]

  • 8. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M, Dezi A, Ferrario F, Capurso I.
    Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239
    [Abstract] [Full Text] [Related]

  • 9. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 11; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 10. Upper gastrointestinal toxicity of rofecoxib and naproxen.
    Delgado Fernández M, Zambrana García JL, Diez García F.
    N Engl J Med; 2001 May 03; 344(18):1398; author reply 1398-9. PubMed ID: 11336056
    [No Abstract] [Full Text] [Related]

  • 11. [Medical treatment of stomach ulcer except in emergency].
    Bretagne JF.
    Gastroenterol Clin Biol; 1996 Jan 03; 20(1 Pt 2):S73-S80. PubMed ID: 8734374
    [No Abstract] [Full Text] [Related]

  • 12. Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.
    Jacobsen RB, Phillips BB.
    Ann Pharmacother; 2004 Sep 03; 38(9):1469-81. PubMed ID: 15213313
    [Abstract] [Full Text] [Related]

  • 13. Prevention of NSAID-induced ulcers in the elderly.
    Geriatrics; 2005 Oct 03; Suppl():3-12; quiz 13-4. PubMed ID: 16334635
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Graham DY.
    N Engl J Med; 1996 Oct 24; 335(17):1322; author reply 1322-3. PubMed ID: 8992333
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.